A detailed history of Sterling Capital Management LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 1,425 shares of ABOS stock, worth $1,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,425
Previous 133 971.43%
Holding current value
$1,738
Previous $330,000 642.73%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$1.72 - $3.27 $2,222 - $4,224
1,292 Added 971.43%
1,425 $2.45 Million
Q3 2024

Nov 12, 2024

BUY
$2.22 - $3.54 $295 - $470
133 New
133 $330,000

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $49.4M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.